Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose efficacy of inhaled prostaglandin I2 vs inhaled prostaglandin E1 in ARDS
2004-001529-88Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Oct 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of epoprostenol and Vasostenoon in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Medical University of Vienna. Started Oct 2004; status: terminated.
02
Drugs
epoprostenolVasostenoon
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2004-001529-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001529-88.